Johannes Zuber
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 41
- Molecular Biology top 0.5%
- Protein Degradation and Inhibitors 40
- CRISPR and Genetic Engineering 21
- Histone Deacetylase Inhibitors Research 20
- Ubiquitin and proteasome pathways 19
- RNA Interference and Gene Delivery 18
- Genomics and Chromatin Dynamics 18
- RNA Research and Splicing 18
- Cancer Research top 1%
- Oncology top 1%
- Immunology top 2%
- Co-authors
- Scott W. LoweAmy RappaportScott C. KoganChristopher R. VakocMatthias MuharMeredith J. TaylorEric WangJames E. Bradner
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Johannes Zuber
159 papers receiving 12.0k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Hematology 2.2k
- Molecular Biology 9.6k
- Cancer Research 1.5k
- Oncology 2.2k
- Immunology 1.1k
Countries citing papers authored by Johannes Zuber
This map shows the geographic impact of Johannes Zuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Zuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Zuber more than expected).
Fields of papers citing papers by Johannes Zuber
This network shows the impact of papers produced by Johannes Zuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Zuber. The network helps show where Johannes Zuber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Johannes Zuber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 18 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 57 | |
| 8 | 2021 | 64 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 29 | |
| 12 | 2020 | 39 | |
| 13 | 2019 | 16 | |
| 14 | 2018 | 83 | |
| 15 | 2018 | 237 | |
| 16 | 2018 | 29 | |
| 17 | Topologically associating domains and chromatin loops depend on cohesin and are regulated by CTCF, WAPL, and PDS5 proteinsbreakdown → | 2017 | 545 |
| 18 | 2017 | 35 | |
| 19 | 2015 | 83 | |
| 20 | 2014 | 93 |
About Johannes Zuber
Johannes Zuber is a scholar working on Hematology, Molecular Biology and Cancer Research, having authored 167 papers that have together received 12.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (41 papers), Protein Degradation and Inhibitors (40 papers), CRISPR and Genetic Engineering (21 papers), Histone Deacetylase Inhibitors Research (20 papers), Ubiquitin and proteasome pathways (19 papers), RNA Interference and Gene Delivery (18 papers), Genomics and Chromatin Dynamics (18 papers) and RNA Research and Splicing (18 papers). The work is most often cited by research in Hematology (2.2k citations), Molecular Biology (9.6k citations) and Cancer Research (1.5k citations). Johannes Zuber has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Scott W. Lowe, Amy Rappaport, Scott C. Kogan, Christopher R. Vakoc, Matthias Muhar, Meredith J. Taylor, Eric Wang, James E. Bradner, Junwei Shi and Gregory J. Hannon. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.